Chartwell Investment Partners’s ChemoCentryx, Inc. CCXI Stock Holding History

Chartwell Investment Partners’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-12,430	Closed	-$637K	–	442
2021 Q1	$637K	Sell	12,430 -667	-5%	-$40.1K	0.02%	388
2020 Q4	$811K	Sell	13,097 -15,954	-55%	-$913K	0.03%	371
2020 Q3	$1.59M	Buy	29,051 +4,692	+19%	+$253K	0.06%	301
2020 Q2	$1.4M	Sell	24,359 -8,897	-27%	-$484K	0.05%	297
2020 Q1	$1.34M	Buy	33,256 +12,340	+59%	+$524K	0.06%	291
2019 Q4	$827K	Buy	+20,916	New	+$367K	0.03%	366

Other funds holding CCXI

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Chartwell Investment Partners's CCXI Position: Q2 2021 in Review

Chartwell Investment Partners sold out of ChemoCentryx, Inc. (CCXI) in Q2 2021, closing a stake of 12,430 shares — an estimated $637K sold.

Chartwell Investment Partners first reported a position in CCXI in Q4 2019 and held it in 6 quarters. The position peaked at $1.59M in Q3 2020. 146 funds tracked by Wall St. Rank hold CCXI as of Q2 2021.

Chartwell Investment Partners reported no remaining ChemoCentryx, Inc. position as of Q2 2021 after selling out during the quarter.
Chartwell Investment Partners sold 12,430 ChemoCentryx, Inc. shares in Q2 2021, an estimated $637K.
Chartwell Investment Partners first reported a position in ChemoCentryx, Inc. in Q4 2019 and held it in 6 quarters.
Chartwell Investment Partners's ChemoCentryx, Inc. position peaked at $1.59M in Q3 2020.
146 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2021.

Based on Chartwell Investment Partners's 13F filing for Q2 2021, filed 19 Jul 2021.